deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT04589949

Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study) (CoV-Early)

Sponsor: Erasmus Medical Center

Conditions Covid19
Interventions ConvP FFP
Updated 6 times since 2020 Last updated: Mar 22, 2022 Started: Oct 12, 2020 Primary completion: Oct 1, 2021 Completion: Mar 1, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

vaccination uptake 80% in the target population/new COVID variant

This PHASE3 trial investigates Covid19 and is currently terminated or withdrawn. Erasmus Medical Center leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotRecruiting~Jan 2022 – ~May 2022 · 4 months · monthly snapshot~May 2022 – ~Jul 2024 · 26 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. May 2022 — Jul 2024 [monthly]

    Terminated PHASE3

    Status: RecruitingTerminated

  4. Jan 2022 — May 2022 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Jan 2022 [monthly]

    Recruiting PHASE3

Show 1 earlier version
  1. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    First recorded

Oct 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Erasmus Medical Center
  • Leiden University Medical Center
  • Prothya Biosolutions
  • ZonMw: The Netherlands Organisation for Health Research and Development
Data source: Erasmus Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .